why choose us

First received: August 06, 2024

Clinical Trial: Predictive Role of KLK10 and Other Neuroinflammatory Molecules on Clinical Outcomes of AIS

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Ischemic Stroke

Study Type: OBSERVATIONAL


Official Title: Predictive Role of Early Blood KLK10 and Other Neuroinflammatory Molecules on Clinical Outcomes of Acute Ischemic Stroke

Brief Summary: This study aims to investigate the dynamic changes and differential expression characteristics of neuroinflammatory molecules such as kallikrein-related peptidase 10 (KLK10), soluble triggering receptor expressed on myeloid cells 2 (sTREM2), and glial fibrillary acidic protein (GFAP) in the plasma of patients with first-ever anterior circulation acute ischemic stroke (AIS).It will analyze the correlation between these molecules and the severity of neurological deficits, infarct volume, brain edema, hemorrhagic…

Read more